OPTI — OptiBiotix Health Income Statement
0.000.00%
- £12.91m
- £11.65m
- £0.64m
- 52
- 10
- 36
- 20
Annual income statement for OptiBiotix Health, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.
R2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 13 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.745 | 1.52 | 2.21 | 0.457 | 0.644 |
Cost of Revenue | |||||
Gross Profit | 0.393 | 0.88 | 1.12 | 0.244 | 0.32 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 2.91 | -1.53 | 3.58 | -10.7 | 2.34 |
Operating Profit | -2.17 | 3.05 | -1.37 | 11.1 | -1.7 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -2.49 | 5.71 | 6.18 | 2.44 | -2.04 |
Provision for Income Taxes | |||||
Net Income After Taxes | -2.37 | 5.8 | 6.26 | 2.59 | -2.04 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -2.37 | 5.8 | 6.26 | 2.59 | -2.04 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -2.37 | 5.8 | 6.26 | 2.59 | -2.04 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.026 | 0.032 | 0.066 | -0.067 | -0.023 |
Dividends per Share |